Skip to main content
Premium Trial:

Request an Annual Quote

Microarrays Used to Predict Chemotherapy Response in Breast Cancer, Lancet Study Reports

NEW YORK, Aug. 1 - A preliminary study published in the Aug. 2 issue of The Lancet reported that a gene expression profiling technique using microarrays could predict which breast cancer sufferers would respond to chemotherapy.

 

The study, which was partially funded by Aventis, was conducted over two years and involved 24 women receiving docetaxel, a common breast cancer chemotherapy drug. Scientists used arrays to find 92 genes that correlated with docetaxel response. This group of genes positively predicted drug response 92 percent of the time.

 

This was the first study to successfully predict chemotherapy response in breast cancer using this technique, according to Jeff Boyd, director of the Gynecology and Breast Cancer Research Laboratory at MemorialSloan-KetteringCancerCenter.

 

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.